✦ LIBER ✦

Low-dose valaciclovir and cytomegalovirus immunoglobulin to prevent cytomegalovirus disease in high-risk renal transplant recipients

✍ Scribed by NIGEL D TOUSSAINT; MARCUS BP TAN; KATHY NICHOLLS; ROWAN G WALKER; SOLOMON J COHNEY

Book ID: 108960915
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 130 KB
Volume: 16
Category: Article
ISSN: 1320-5358
DOI: 10.1111/j.1440-1797.2010.01379.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose valaciclovir prophylaxis agains

Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients

✍ SrikanthP. Reddy; Ashok Handa; Liamchin Tan; Andrea Devaney; David Hughes; Phill 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 171 KB

Fatal cytomegalovirus disease in a high-

Fatal cytomegalovirus disease in a high-risk renal transplant recipient

✍ Frank Tenney; Abdullah Sakarcan 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 62 KB

Low and high molecular weight cytomegalo

Low and high molecular weight cytomegalovirus-specific immunoglobulin M antibody in renal transplant patients with cytomegalovirus infections

✍ Dr. H. J. O'Neill; P. V. Shirodaria; D. M. Simpson 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Efficacy and safety of low-dose valganci

Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients

✍ Jeong M. Park; Kathleen D. Lake; Juan D. Arenas; Robert J. Fontana 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

The efficacy and safety of valganciclovir (VGCV) for cytomegalovirus (CMV) prophylaxis in liver transplant recipients has not been established. We retrospectively compared the efficacy and safety of low-dose oral VGCV (450 mg once daily for 90 days) and standard oral ganciclovir (1 g three times a d

Risk factors for cytomegalovirus infecti

Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy

✍ Y. J. Kraat; M. H. L. Christiaans; F. H. M. Nieman; P. M. Berg-Loonen; J. P. Hoo 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 536 KB

Failure of high-dose oral acyclovir with

Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants

✍ Thomas C. Bailey; Neil A. Ettinger; Gregory A. Storch; Elbert P. Trulock; Dougla 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 104 KB